Isomorphic Labs secures $2.1 Billion funding to scale its AI drug design engine
- Written by PR Newswire
Isomorphic Labs will use the funding to power its world-leading AI drug design engine, scale its business globally and progress its drug candidate pipeline.
LONDON, May 12, 2026 /PRNewswire/ -- Isomorphic Labs, an AI-first drug design and development company, today announced it has raised $2.1 Billion in Series B funding. This latest round of...
Read more: Isomorphic Labs secures $2.1 Billion funding to scale its AI drug design engine














